Neoadjuvant Concurrent Chemoradiation With Weekly Docetaxel/Cisplatin for Resectable IIIA-N2 NSCLC
Clinical trial NCT01771289 · UNKNOWN
Trial details
- NCT number
- NCT01771289
- Sponsor
- Peking University People's Hospital
- Status
- UNKNOWN
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2013-01-01
- Primary completion
- 2017-01-01
- Enrollment
- 50
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.